在脊椎关节炎中决定转换第一种生物治疗的因素:来自RBSMR注册表的数据
Oumaima Idrissi Ouali1, Imane El Mezouar1, Nessrine Akasbi1
1Hassan II University Hospital, Rheumatology, Faculty of Medicine, Pharmacy and Dental Medicine, Sidi Mohamed Ben Abdellah University, Fez, Morocco.
Current rheumatology reviews
|January 22, 2026
概括
高龄和较高的疾病活性预测脊髓炎患者的生物治疗切换. 了解这些因素有助于个性化生物疾病修饰性抗风湿性药物治疗,以获得更好的结果.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
背景情况:
- 生物疗法改善了脊髓炎 (SpA) 管理.
- 治疗转向替代生物药物的原因有很多.
- 在个性化治疗策略中确定切换辅助器的因素.
研究的目的:
- 确定与SPA患者切换初始生物治疗相关的因素.
- 根据患者的个人资料,为量身定制的生物处方提供信息.
主要方法:
- 从国家登记处 (2017年6月至2019年1月) 分析了成人SPA患者.
- ASAS标准定义了患者选择,随访时间为3年.
- 单变量和多变量逻辑回归确定了转换到第一个bDMARDs的因素.
主要成果:
- 194名SPA患者中有46人 (23.71%) 转换为第二种生物药物.
- 切换与晚年 (p=0.030) 和更高的BASDAI (p=0.024) 相关.
- 心脏病和中风等并发症的缺失也预测了切换 (p=0.011).
结论:
- 生物治疗改善了SPA的预后,需要对治疗切换进行监测.
- 晚年,皮质类固醇病史和特定的并发症与治疗转换有关.
- 对于临床建议,需要对更大的队列和免疫原性数据进行进一步的研究.
相关概念视频
Factors Affecting Drug Biotransformation: Biological
527
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
527
Switching of BJT
812
Switching behavior in Bipolar Junction Transistors (BJTs) is a fundamental aspect utilized in various electronic circuits, particularly for digital logic applications like switches and amplifiers. In a typical switching circuit, a BJT alternates between cut-off and saturation modes, corresponding to the "off" and "on" states, respectively, thus behaving like an ideal switch.
Cut-off Mode ("Off" State): In this state, both the emitter-base and collector-base junctions are...
Cut-off Mode ("Off" State): In this state, both the emitter-base and collector-base junctions are...
812
One-Compartment Open Model: Urinary Excretion Data and Determination of k
615
The one-compartment open model leverages urinary excretion data to estimate renal clearance, which gauges the kidney's capacity to expel a drug. This method offers several benefits, including directly measuring drug elimination and assessing the kidney's contribution to overall drug clearance. However, this approach has limitations. It assumes sole renal excretion of the drug, which is not true for all drugs. Accurate urinary excretion and plasma drug concentration measurement can also...
615
Biological Effects of Radiation
17.7K
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they...
17.7K
Transcription Factors
82.3K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
82.3K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
515
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
515


